Overview
Higher EdPhase 4ketaminepsilocybinOtherMDMA
Emory University School of Medicine conducts psychedelic research in psychiatry and behavioral sciences.
Visit WebsiteAtlanta, GA
9
Clinical Trials
0
Open Roles
Open Positions
No open positions at this time
Research Areas
Clinical Pipeline(9)
Terminated·Phase 4·ketamine
Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients
KetamineOtolaryngeal Cancer
Completed·Phase 1·psilocybin
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
PsilocybinHematopoietic and Lymphoid Cell Neoplasm
Completed·N/A·Other
Heart Rate Variability in Depression
Video TaskMajor Depressive Disorder
Recruiting·Phase 2·MDMA
MDMA-Assisted Massed Exposure Therapy for PTSD
3,4-Methylenedioxymethamphetamine (MDMA)Post Traumatic Stress Disorder
Recruiting·Early Phase 1·ketamine
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
KetamineMajor Depressive Disorder
Completed·Phase 1·ketamine
Intranasal (NAS) Ketamine for Cancer Pain
Intranasal ketamineCancer
Terminated·Phase 4·Other
Paravertebral Nerve Blocks in Neonates
Paravertebral Nerve BlockCongenital Heart Disease
Enrolling by Invitation·Phase 2·MDMA
MDMA Plus Exposure Therapy for PTSD
MDMAPTSD
Not Yet Recruiting·Phase 2·psilocybin
Psilocybin-Assisted Therapy
psilocybinPTSD